Mometasonfuroat Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroat Teva, is a corticosteroid presented as a nasal spray for endosinusial, nasal use. It reduces inflammation in the nasal passages and sinuses, helping to control symptoms of allergic rhinitis, nasal polyps and sinusitis. GNH USA supplies Mometasonfuroat Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasonfuroat Teva is a topical corticosteroid that acts on inflammatory processes of the upper respiratory tract.

Allergic rhinitis: alleviates nasal congestion, itching and sneezing caused by allergic inflammation. Nasal polyps: reduces polyp size and improves nasal airflow. Sinusitis: diminishes mucosal swelling and promotes sinus drainage.

Mometasonfuroat Teva may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleed). - Throat irritation. - Cough. - Unpleasant taste.

Serious or Rare Side Effects: - Nasal septum perforation. - Secondary fungal or bacterial infection of the nasal mucosa. - Adrenal suppression with prolonged high‑dose use. - Elevated intra‑ocular pressure or glaucoma. - Severe allergic reaction (anaphylaxis).

Before using Mometasonfuroat Teva, consider the following safety measures.

Avoid use in patients with known hypersensitivity to mometasone furoate or any excipients. Do not use during active untreated nasal infections, especially fungal. Exercise caution in patients with glaucoma, cataracts, or uncontrolled diabetes. Monitor for signs of adrenal insufficiency during long‑term therapy. Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mometasonfuroat Teva can interact with other medications that affect corticosteroid metabolism or increase infection risk.

Major Interactions (Avoid): - Systemic CYP3A4 inhibitors (e.g., ketoconazole) that may raise local steroid exposure. - Live intranasal vaccines (e.g., influenza) due to potential reduced vaccine efficacy.

Moderate Interactions (Monitor Closely):\n- Concurrent use of other intranasal corticosteroids may increase systemic absorption. - Antifungal agents used intranasally may mask infection signs. - Immunosuppressive drugs that could heighten infection risk.